{"transactions":[{"id":735281,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":37481,"kind":"person","name":"Roman Shawn David","position":1,"cik":"0002048672","reported_name":"Roman Shawn David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-06-17T21:15:02.000Z","date":"2026-06-15","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-26-029122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226029122/ownership.xml","form_type":"4"}},{"id":735280,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":37481,"kind":"person","name":"Roman Shawn David","position":1,"cik":"0002048672","reported_name":"Roman Shawn David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T21:15:02.000Z","date":"2026-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":10533,"price":4.6,"value":48451.8,"ownership":{"direct":false,"nature":"By The Roman Family Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary."}],"balance_after":16467,"source":{"system":"sec-edgar","filing":"0001493152-26-029122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226029122/ownership.xml","form_type":"4"}},{"id":735279,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":37481,"kind":"person","name":"Roman Shawn David","position":1,"cik":"0002048672","reported_name":"Roman Shawn David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T21:15:02.000Z","date":"2026-06-15","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":3.23,"value":48450.0,"ownership":{"direct":false,"nature":"By The Roman Family Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-26-029122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226029122/ownership.xml","form_type":"4"}},{"id":738808,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":37481,"kind":"person","name":"Roman Shawn David","position":1,"cik":"0002048672","reported_name":"Roman Shawn David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2026-06-15T23:00:07.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":88044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":88044,"derivative":{"exercise_price":4.65,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":88044},"source":{"system":"sec-edgar","filing":"0001493152-26-028769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226028769/ownership.xml","form_type":"4"}},{"id":928371,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":37481,"kind":"person","name":"Roman Shawn David","position":1,"cik":"0002048672","reported_name":"Roman Shawn David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-29T22:21:08.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 27, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 12,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":1.8,"expiration_date":"2026-03-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001493152-26-004254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226004254/ownership.xml","form_type":"4"}},{"id":928370,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":37481,"kind":"person","name":"Roman Shawn David","position":1,"cik":"0002048672","reported_name":"Roman Shawn David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-29T22:21:08.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":1.8,"value":21600.0,"ownership":{"direct":false,"nature":"By The Roman Family Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001493152-26-004254","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226004254/ownership.xml","form_type":"4"}},{"id":1301137,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":37481,"kind":"person","name":"Roman Shawn David","position":1,"cik":"0002048672","reported_name":"Roman Shawn David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2025-01-17T21:07:08.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":1.42,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-25-002766","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315225002766/ownership.xml","form_type":"4"}}]}